Compare · MOS vs NXTS
MOS vs NXTS
Side-by-side comparison of Mosaic Company (MOS) and Nexentis Technologies Inc. (NXTS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MOS and NXTS operate in Agricultural Chemicals (Industrials), so they compete in similar markets.
- MOS is the larger of the two at $6.02B, about 5935.3x NXTS ($1.0M).
- Over the past year, MOS is down 36.4% and NXTS is down 97.6% - MOS leads by 61.2 points.
- Both names hit the wire about 4 times in the past 4 weeks.
- MOS has more recent analyst coverage (25 ratings vs 0 for NXTS).
- Company
- Mosaic Company
- Nexentis Technologies Inc.
- Price
- $18.82-0.71%
- $0.61-2.56%
- Market cap
- $6.02B
- $1.0M
- 1M return
- -25.87%
- -48.05%
- 1Y return
- -36.37%
- -97.55%
- Industry
- Agricultural Chemicals
- Agricultural Chemicals
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 4
- 4
- Recent ratings
- 25
- 0
Mosaic Company
The Mosaic Company, through its subsidiaries, produces and markets concentrated phosphate and potash crop nutrients in North America and internationally. The company operates through three segments: Phosphates, Potash, and Mosaic Fertilizantes. It owns and operates mines, which produce concentrated phosphate crop nutrients, such as diammonium phosphate, monoammonium phosphate, and ammoniated phosphate products; and phosphate-based animal feed ingredients primarily under the Biofos and Nexfos brand names, as well as produces a double sulfate of potash magnesia product under K-Mag brand name. The company also produces and sells potash for use in the manufacturing of mixed crop nutrients and animal feed ingredients, and for industrial use; and for use in the de-icing and as a water softener regenerant. In addition, it provides nitrogen-based crop nutrients and animal feed ingredients, and other ancillary services; and purchases and sells phosphates, potash, and nitrogen products. The company sells its products to wholesale distributors, retail chains, farmers, cooperatives, independent retailers, and national accounts. The Mosaic Company was incorporated in 2004 and is headquartered in Tampa, Florida.
Latest MOS
- MOSAIC ANNOUNCES THIRD QUARTER 2026 EARNINGS RESULTS DATES
- Mosaic downgraded by RBC Capital Mkts with a new price target
- Director Little Sonya C was granted 65 shares, increasing direct ownership by 0.89% to 7,351 units (SEC Form 4)
- SEC Form SD filed by Mosaic Company
- Mosaic Company filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- THE MOSAIC COMPANY ANNOUNCES EXECUTIVE LEADERSHIP CHANGES
- KeyBanc Capital Markets initiated coverage on Mosaic
- Mosaic Company filed SEC Form 8-K: Events That Accelerate or Increase a Direct Financial Obligation
- MOSAIC ANNOUNCES QUARTERLY DIVIDEND OF $0.22 PER SHARE
- SVP - Chief Admin Officer Precourt Walter F. Iii sold $508,760 worth of shares (23,000 units at $22.12), decreasing direct ownership by 17% to 116,198 units (SEC Form 4)
Latest NXTS
- Nexentis: MitoCareX Bio Expands Computational Biology Capabilities to Advance Disease-Pathway Analysis
- Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud
- SEC Form 8-K filed by Nexentis Technologies Inc.
- SEC Form PRE 14A filed by Nexentis Technologies Inc.
- Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board
- Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery
- Nexentis Technologies Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- SEC Form 10-Q filed by Nexentis Technologies Inc.
- Nexentis Technologies Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
- Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign